VPTDF - Ventripoint Announces Filing of Articles of Amendment
(TheNewswire)
Toronto, Ontario – TheNewswire –January 13, 2021 - Ventripoint Diagnostics Ltd.(" Ventripoint " or the " Company "), (TSXV:VPT ) ( OTC:VPTDF) announces it has filed articles of amendment inaccordance with the Canada Business Corporations Act to change theprovince in which the registered office of the Company is located fromAlberta to Ontario. Shareholders of the Company approved the amendmentat the annual and special meeting of shareholders held on December 14,2020.
A copy of the articles of amendment will be posted onthe Company’s issuer profile on SEDAR at www.SEDAR.com
About Ventripoint DiagnosticsLtd.
Ventripoint has become anindustry leader in the application of AI (Artificial Intelligence) toechocardiography. Ventripoint's VMS products are powered by itsproprietary KBR technology, which is the result of a decade ofdevelopment and provides accurate volumetric cardiac measurementsequivalent to MRI. This affordable, gold-standard alternative allowscardiologists greater confidence in the management of their patients.Providing better care to patients serves as a springboard and basicstandard for all of Ventripoint's products that guide our futuredevelopments. In addition, VMS+ is versatile and can be used with allultrasound systems from any vendor supported by regulatory marketapprovals in the U.S., Europe and Canada.
For further information, pleasecontact:
Dr. George Adams
Tel: 519- 803-6937
Neither the TSX Venture Exchange nor its RegulationServices Provider (as that term is defined in the policies of the TSXVenture Exchange) accepts responsibility for the adequacy or accuracyof this news release.
Copyright (c) 2021 TheNewswire - All rights reserved.